Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 4, Pages 780
Publisher
MDPI AG
Online
2021-02-14
DOI
10.3390/cancers13040780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival
- (2020) Afroditi Nanou et al. BRITISH JOURNAL OF CANCER
- SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy
- (2020) Vincenza Conteduca et al. MOLECULAR CANCER THERAPEUTICS
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
- (2020) Elaine Kilgour et al. CANCER CELL
- Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
- (2020) Martha Zavridou et al. Scientific Reports
- Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
- (2019) Klaus Pantel et al. CLINICAL CHEMISTRY
- Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
- (2019) Adam Sharp et al. EUROPEAN UROLOGY
- A pilot study of prostate‐specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer
- (2019) Channing J. Paller et al. PROSTATE
- Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes
- (2019) Mohammed Nimir et al. Cells
- Applications of liquid biopsies for cancer
- (2019) Austin K. Mattox et al. Science Translational Medicine
- Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- In Situ Detection and Quantification of AR-V7, AR-FL, PSA, andKRASPoint Mutations in Circulating Tumor Cells
- (2018) Amin El-Heliebi et al. CLINICAL CHEMISTRY
- RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients
- (2018) Corinna Keup et al. CLINICAL CHEMISTRY
- Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies
- (2018) Martha Zavridou et al. CLINICAL CHEMISTRY
- Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
- (2018) Afroditi Nanou et al. Oncotarget
- Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
- (2018) Howard I. Scher et al. JAMA Oncology
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Landmarks in prostate cancer
- (2018) Niranjan J. Sathianathen et al. Nature Reviews Urology
- Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management
- (2018) Anjui Wu et al. CLINICAL CHEMISTRY
- Liquid Biopsies
- (2018) Evi Lianidou et al. GENES CHROMOSOMES & CANCER
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies
- (2018) Emma E. van der Toom et al. Nature Reviews Urology
- Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting
- (2017) Parvez M. Lokhandwala et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
- (2017) Lydia Giannopoulou et al. Oncotarget
- Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
- (2016) Tobias M. Gorges et al. CLINICAL CHEMISTRY
- Gene expression profiling and DNA methylation analyses of CTCs
- (2016) Evi S. Lianidou Molecular Oncology
- Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer
- (2016) Tobias M. Gorges et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
- (2015) Vanesa Nogales et al. Oncotarget
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
- (2011) M. Chimonidou et al. CLINICAL CHEMISTRY
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now